Recent research has shown that the mosquito-borne Zika virus has the potential to cause serious health problems, including severe birth defects in humans. But the damaging effects of Zika might not end there: results of a new mouse study show that the virus may also have an unexpected negative—and possibly long-lasting—impact on male fertility.
In work published in the journal Nature, an NIH-funded research team found that Zika infections can persist for many weeks in the reproductive systems of male mice . As a result of this infection, levels of testosterone and other sex hormones drop, sperm counts fall, and, in some animals, the testicles shrink to 1/10th of their normal size, possibly irreversibly. All of this adds up to Zika-infected male mice that are significantly less fertile than their healthy counterparts—producing about a quarter as many viable offspring as normal when mated with female mice. While mice are certainly not humans, the results underscore the urgent need for additional research to examine the full spectrum of Zika’s health effects in men, women, and children of both sexes.
Tags: antibodies, dengue virus, fertility, Guillain-Barré syndrome, infectious disease, inhibin B, male fertility, male reproductive system, male reproductive tract, male sex hormones, men, men's health, mosquito, mosquito-borne illnesses, pregnancy, primary spermatocytes, reproductive system, Sertoli cells, sperm, spermatogonia, testes, testicles, testosterone, virology, Zika, Zika virus
In response to the health threat posed by the recent outbreak of Zika virus in Latin America and its recent spread to Puerto Rico and Florida, researchers have been working at a furious pace to learn more about the mosquito-borne virus. Considerable progress has been made in understanding how Zika might cause babies to be born with unusually small heads and other abnormalities and in developing vaccines that may guard against Zika infection.
Still, there remains an urgent need to find drugs that can be used to treat people already infected with the Zika virus. A team that includes scientists at NIH’s National Center for Advancing Translational Sciences (NCATS) now has some encouraging news on this front. By testing 6,000 FDA-approved drugs and experimental chemical compounds on Zika-infected human cells in the lab, they’ve shown that some existing drugs might be repurposed to fight Zika infection and prevent the virus from harming the developing brain . While additional research is needed, the new findings suggest it may be possible to speed development and approval of new treatments for Zika infection.
Tags: Aedes mosquito, birth defects, CDK inhibitors, drug repurposing, drug screening, Ebola virus, emiricasan, microcephaly, mosquito, neural progenitor cells, niclosamide, organoids, PHA-690509, repurposing drugs, small-molecule inhibitors, vaccine, virology, Zika, Zika vaccine, Zika virus
Recently, public health officials have raised major concerns over the disturbing spread of the mosquito-borne Zika virus among people living in and traveling to many parts of Central and South America . While the symptoms of Zika infection are typically mild, grave concerns have arisen about its potential impact during pregnancy. The concerns stem from the unusual number of births of children with microcephaly, a very serious condition characterized by a small head and damaged brain, coinciding with the spread of Zika virus. Now, two new studies strengthen the connection between Zika and an array of birth defects, including, but not limited to, microcephaly.
In the first study, NIH-funded laboratory researchers show that Zika virus can infect and kill human neural progenitor cells . Those progenitor cells give rise to the cerebral cortex, a portion of the brain often affected in children with microcephaly. The second study, involving a small cohort of women diagnosed with Zika virus during their pregnancies in Rio de Janeiro, Brazil, suggests that the attack rate is disturbingly high, and microcephaly is just one of many risks to the developing fetus. 
Tags: birth defects, brain, brain development, Brazil, cerebral cortex, global health, human neural progenitor cells, infectious disease, iPS, microcephaly, mosquito, mosquito-borne illnesses, neurogenesis, neurology, pediatrics, pregnancy, virology, Zika, Zika virus
Credit: Kraemer et al. eLife 2015;4:e08347
For decades, the mosquito-transmitted Zika virus was mainly seen in equatorial regions of Africa and Asia, where it caused a mild, flu-like illness and rash in some people. About 10 years ago, the picture began to expand with the appearance of Zika outbreaks in the Pacific islands. Then, last spring, Zika popped up in South America, where it has so far infected more than 1 million Brazilians and been tentatively linked to a steep increase in the number of babies born with microcephaly, a very serious condition characterized by a small head and brain . And Zika’s disturbing march may not stop there.
In a new study in the journal The Lancet, infectious disease modelers calculate that Zika virus has the potential to spread across warmer and wetter parts of the Western Hemisphere as local mosquitoes pick up the virus from infected travelers and then spread the virus to other people . The study suggests that Zika virus could eventually reach regions of the United States in which 60 percent of our population lives. This highlights the need for NIH and its partners in the public and private sectors to intensify research on Zika virus and to look for new ways to treat the disease and prevent its spread.
Tags: Aedes aegypti, Aedes albopictus, Aedes mosquitoes, Asian tiger mosquitoes, birth defects, Brazil, chikungunya, child health, climate, dengue, disease control, disease prevention, disease transmission, epidemic, global health, Guillain-Barré syndrome, infectious disease, microcephaly, mosquito, pediatrics, pregnancy, travel, virology, virus, yellow fever mosquitoes, Zika, Zika virus
Malaria has confounded biomedical researchers for decades because it’s been impossible so far to develop a vaccine that offers a high level of protection. But, thanks to a different approach to vaccine design and delivery, there’s hope that we may have finally turned the corner in the fight against this mosquito-borne health threat. (more…)